Three pharmacopeias have launched their first coordinated prospective harmonization project covering a drug substance and finished dosage form, using osimertinib as the test case.
Three pharmacopeias have launched their first coordinated prospective harmonization project covering a drug substance and finished dosage form, using osimertinib as the test case.